PAZOPANIB vs PEGCETACOPLAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PAZOPANIB vs PEGCETACOPLAN: Safety Overview
| Metric | PAZOPANIB | PEGCETACOPLAN |
|---|---|---|
| Total FAERS Reports | 21,208 | 1,369 |
| Deaths Reported | 5,612 | 84 |
| Death Rate | 26.5% | 6.1% |
| Hospitalizations | 4,347 | 252 |
| Average Patient Age | 61.2 yrs | 65.4 yrs |
| % Female Patients | 41.2% | 70.5% |
| FDA Approval Date | Apr 23, 2024 | Feb 17, 2023 |
| Manufacturer | Golden State Medical Supply, Inc. | Apellis Pharmaceuticals, Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |